Friday, July 20, 2018

Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: $GENE.V, TSXV: $META.V, CSE: $CHV.C


Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: $GENE.V, TSXV: $META.V, CSE: $CHV.C

July 20th Potcast sponsored by Lexaria Bioscience Corp. ( CSE: $LXX.C ) (OTC: $LXRP) a #Cannabis company with a new disruptive drug delivery platform: DehydraTECH



Pt. Roberts, WA; Delta, BC –July 20, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca  release today’s edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:


Today’s podcast overview/transcript:

Good morning and welcome to another Investorideas.com potcast ; looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on the OTC as LXRP.  Lexaria has developed a new disruptive drug delivery platform: DehydraTECH The Company’s patented technology changes the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120 min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble vitamins.
Learn more about Lexaria at www.lexariabioscience.com

Today’s podcast features news  announcements from INVICTUS MD STRATEGIES CORP. trading (TSX-Venture  GENE and  OTC: IVITF) , National Access Cannabis Corp. ( TSX-VENTURE: META) and Canada House Wellness Group Inc. (CSE: CHV) .


INVICTUS MD STRATEGIES CORP. announced that it has entered into a binding letter of intent ("LOI") to acquire 100% of the issued and outstanding shares of a medical clinic and cannabis retail company ("Clinic and Retail Co") that operates medical clinics in, Alberta, and is awaiting final review and approval for a retail cannabis license from the Alberta Gaming and Liquor Commission ("AGLC).

The medical clinics' patient-first business model features educators and physicians on-site to educate patients about medical cannabis and how to access it safely in Canada. In four easy steps, patients can see a physician, access educational support, and register with a licensed producer to begin receiving product. The cannabis clinic has 3,400 patients registered under Access to Cannabis for Medical Purposes Regulations ("ACMPR"), providing a direct channel to Invictus owned Licensed Producers ("LPs"), fully licensed under ACMPR.

National Access Cannabis Corp. today announced that it has entered into a loan agreement and connected collateral documents with Opaskwayak Cree Nation ("OCN") in respect of a secured loan, pursuant to which OCN will lend up to $35,000,000 to NAC. The Company plans to use the proceeds from the Loan to build-out up to 50-70 cannabis retail locations across Western Canada in 2018 under NAC's retail brand Meta Cannabis Supply Co.™ ("META"), as well as for working capital purposes. META stores are currently under construction in Manitoba.

The Board of Directors of Canada House Wellness Group Inc. announced today the hiring of Alex Kroon as Executive Vice-President of the Company and President of the Company’s wholly owned subsidiary Marijuana for Trauma (“MFT”) as well as the hiring of Steven Pearce as Vice-President, Legal.  Alex Kroon’s start date is August 13th, 2018 and Steven Pearce is starting immediately.  Both Steven and Alex will be part of the Canada House executive council. Michael Southwell, MFT’s Vice-President from 2013-2017 and President from 2017-2018 will resign as President of MFT effective August 13th, 2018 but will continue as a valued and important member of Canada House’s leadership team in his capacity as a member of the Board.  The Board would also like to thank Riley McGee for his efforts over the past year in the management of MFT.

MFT was founded by Fabian Henry and Mike Southwell in 2013 and has grown under their direction to one of Canada’s leading cannabinoid therapy companies, with 11 clinics spanning six provinces providing leading treatment plans and support to a variety of medical patients, including military veterans, first responders, law enforcement, and civilians with, among other conditions, PTSD.


Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of invest

This podcast is sponsored by Lexaria Bioscience Corp. ( CSE: LXX) (OTC: LXRP)

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECHTM delivery technology. Lexaria's technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.  
Investorideas.com cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site  Global Cannabis Investing at www.Globalcannabisinvesting.com


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp


Follow us on Social Media





Contact Investorideas.com

800-665-0411




Do you trade or invest in Marijuana / Hemp Stocks?  Check out our stock directory of publicly traded  CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
Join our Group on Linkedin  and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing



Thursday, July 19, 2018

Investorideas.com - #Cannabisstocks: CROP (CSE:CROP) (OTC:CRXPF) Receives Water Permits and Nears Completion of Its Second Washington Greenhouse Project: 'The Dozen'

Investorideas.com - #Cannabisstocks: CROP (CSE:CROP) (OTC:CRXPF) Receives Water Permits and Nears Completion of Its Second Washington Greenhouse Project: 'The Dozen'

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - #Cannabisstocks: MPX (CSE:MPX) (OTC:MPXEF) Enters Into Extraction Agreement With Southern California's Largest Cannabis Processing Facility, Case Farms Collective

Investorideas.com - #Cannabisstocks: MPX (CSE:MPX) (OTC:MPXEF) Enters Into Extraction Agreement With Southern California's Largest Cannabis Processing Facility, Case Farms Collective

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - #Cannabisstocks: FSD Pharma (CSE:HUGE) (OTC:FSDDF) Enters Into Saskatchewan Wholesale Supply MOU of Up To 5,000 Kilograms With High Tide Ventures

Investorideas.com - #Cannabisstocks: FSD Pharma (CSE:HUGE) (OTC:FSDDF) Enters Into Saskatchewan Wholesale Supply MOU of Up To 5,000 Kilograms With High Tide Ventures

Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSX: $TGOD.TO, TSXV: $EMH.V, TSXV: $N.V, CSE: $IAN.C, CSE: $BE.C


Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSX: $TGOD.TO, TSXV: $EMH.V, TSXV: $N.V, CSE: $IAN.C, CSE: $BE.C

July 19th Potcast sponsored by Lexaria Bioscience Corp. ( CSE: $LXX.C ) (OTC: $LXRP) and its drug delivery platform: DehydraTECH


Pt. Roberts, WA; Delta, BC –June 21, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca  release today’s edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:


Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast; looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on the OTC as LXRP.  Lexaria has developed a new disruptive drug delivery platform: DehydraTECH The Company’s patented technology changes the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120 min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble vitamins.
Learn more about Lexaria at www.lexariabioscience.com

Today we will be looking at announcements from The Green Organic Dutchman Holdings Ltd. trading on the TSX as TGOD, Emerald Health Therapeutics, Inc. trading on the TSX-Venture as EMH, Namaste Technologies Inc. trading on the TSX-Venture as N, iAnthus Capital Holdings, Inc. trading on the CSE as IAN and the OTCQB as ITHUF and Beleave Inc. trading on the CSE as BE.

The Green Organic Dutchman Holdings Ltd. announced its intention to complete a spinoff transaction by way of plan of arrangement, pursuant to which the Company will distribute a dividend consisting of a warrant in a new corporation (“TGOD Acquisitions”) to shareholders. The new corporation will be engaged in the acquisition and development of worldwide opportunities. 

TGOD has met with emerging cannabis companies from around the globe and acquired a deep understanding, including proprietary knowledge, of all facets of the cannabis industry. These companies are not considered core assets in TGOD’s business plan, and accordingly, they have not been pursued to date. However, the Company now wishes to monetize this unique situation for the benefit of TGOD shareholders. After consultation with multiple financial institutions, TGOD Acquisitions plans to execute a series of staged financings and acquisitions leading to a late 2018 target IPO date.7

Emerald Health Therapeutics, Inc. have signed a definitive agreement to acquire the remaining shares of Northern Vine Canada Inc. (Northern Vine), owned by Abattis Bioceuticals Corp. (CSE:ATT) (OTC:ATTBF), for $2 million in cash and $4 million in shares of Emerald stock. This transaction increases Emerald’s ownership of Northern Vine from 65% to 100%. Northern Vine is a Licensed Dealer (LD) under the provisions of the Canadian Controlled Drugs and Substances Act.

“Product innovation is a primary pillar of Emerald’s global business strategy. The acquisition of Northern Vine allows us to leverage its dealer license and research and development facility to advance our research plans to develop cannabis formulations supporting new products for both recreational purposes and to treat a broad spectrum of human conditions and diseases,” said Chris Wagner, CEO of Emerald. “The dealer license would also enable Emerald to cost effectively source non-dried-flower cannabis products from suppliers in other countries.”




Namaste Technologies Inc. announced that the company has submitted applications to the Apple and Google Play stores in order to launch its latest mobile application, Uppy Cannabis Journal. Uppy Cannabis Journal is the first artificial intelligence ("AI") driven medical cannabis app, which is designed to collect direct feedback on cannabis strains and over time provide strain and cannabis hardware recommendations. Namaste has implemented its AI technology through the Company's wholly owned subsidiary Findify AB ("Findify" or "Findify.io") and has fed over 2 million pieces of unique data to the platform which forms the base on which the algorithm will evolve and adapt itself to better understand the effects of cannabis strains in relation to treatment of many symptoms.

Through Uppy Cannabis Journal, Namaste's customers and medical cannabis patients will have the access to journal their experiences using various strains of cannabis to treat their symptoms. The data collected over time will allow the algorithm to characterize the way different strains of cannabis benefit different people suffering from different symptoms. The goal of the Uppy Cannabis Journal is to develop a shopping experience whereby patients are provided with the best possible strain recommendations personalized for their needs, based on factual data collected through Namaste's network of e-commerce sites, combined with user-feedback and AI technology.

iAnthus Capital Holdings, Inc., which owns, operates and partners with licensed cannabis operations throughout the United States, announced that Mayflower Medicinals, Inc. ("Mayflower"), a Massachusetts non-profit Registered Marijuana Dispensary ("RMD") license holder affiliated with the Company, is opening its flagship medical cannabis dispensary in Boston.
Located in the neighborhood of Allston, the dispensary will offer patients a full spectrum of medical cannabis products in the form of flower, tinctures, concentrates, oils and vaporizers. Mayflower is the second license holder to open a dispensary within the city of Boston.   This inaugural Mayflower location is the 34th dispensary to open within the commonwealth of Massachusetts, which has a population of approximately 6.7 million people.

Beleave Inc. announced the acquisition of 100% of the outstanding shares of Seven Oaks Inc. in an all share deal valued at $3,000,000.
"Seven Oaks has a proven track record of working collaboratively to secure wholesale and distribution agreements with retailers across Canada," said Beleave CEO, Andrew Wnek. "Beleave breaking into the recreational market with solid agreements and impactful branding will be a monumental development for us. Seven Oaks' upcoming distribution will not only improve access to our products for many Canadians, it is also continuing our commitment to driving profitability and value for our shareholders."
Seven Oaks' branding appeals to consumers, both conceptually and in the quality it invokes, attracting them to become repeat customers. This acquisition bridges the gap between sourcing cannabis products from an established producer and retailing by leveraging Seven Oak's marketing platform to provide consistent, recognizable quality across Canada.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


This podcast is sponsored by Lexaria Bioscience Corp. ( CSE: LXX) (OTC: LXRP)

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECHTM delivery technology. Lexaria's technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.  
Investorideas.com cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site  Global Cannabis Investing at www.Globalcannabisinvesting.com


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp


Follow us on Social Media





Contact Investorideas.com

800-665-0411




Do you trade or invest in Marijuana / Hemp Stocks?  Check out our stock directory of publicly traded  CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
Join our Group on Linkedin  and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing


Wednesday, July 18, 2018

Investorideas.com - CSE New #Cannabis Stock Listing: Chemesis International Inc. (CSI)

Investorideas.com - CSE New #Cannabis Stock Listing: Chemesis International Inc. (CSI)

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - #Cannabisstocks: FluroTech Ltd. (TSXV: TEST) Announces the Ability to Biomark Cannabis Oil

Investorideas.com - #Cannabisstocks: FluroTech Ltd. (TSXV: TEST) Announces the Ability to Biomark Cannabis Oil

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - #Cannabisstocks: True Leaf (CSE: MJ) (OTCQB: TRLFF) Campus Project Remains on Schedule for Fall 2018 Completion

Investorideas.com - #Cannabisstocks: True Leaf (CSE: MJ) (OTCQB: TRLFF) Campus Project Remains on Schedule for Fall 2018 Completion

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - #Cannabisstocks: Emblem (TSXV:EMC) (TSXV:EMC.WT) (OTCBB:EMMBF) Announces $3 Million Strategic Equity Investment in Natura Naturals and 9,000 kg Supply Agreement over three years

Investorideas.com - #Cannabisstocks: Emblem (TSXV:EMC) (TSXV:EMC.WT) (OTCBB:EMMBF) Announces $3 Million Strategic Equity Investment in Natura Naturals and 9,000 kg Supply Agreement over three years

Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: NASDAQ: $CRON, TSX: $EMC.TO, TSXV: $GENE.V, TSXV: $N.V, CSE: $MJ.C


Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: NASDAQ: $CRON, TSX: $EMC.TO, TSXV: $GENE.V, TSXV: $N.V, CSE: $MJ.C

July 18th Potcast sponsored by Lexaria Bioscience Corp. ( CSE: $LXX.C ) (OTC: $LXRP) a #Cannabis company with a new disruptive drug delivery platform: DehydraTECH 



Pt. Roberts, WA; Delta, BC –July 18, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca  release today’s edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:


Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast – looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on the OTC as LXRP.  Lexaria has developed a new disruptive drug delivery platform: DehydraTECH The Company’s patented technology changes the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120 min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble vitamins.
Learn more about Lexaria at www.lexariabioscience.com

Today we will be looking at announcements from Cronos Group Inc. trading on the NASDAQ and TSX as CRON, Emblem Corp. trading on the TSX-Venture as EMC and the OTCBB as EMMBF, INVICTUS MD STRATEGIES CORP trading on the TSX-Venture as GENE and the OTC as IVITF, Namaste Technologies Inc. trading on the TSX-Venture as N and True Leaf Medicine International Ltd. trading on the CSE as MJ and the OTCQB as TRLFF.

Cronos Group Inc. announced that it has entered into a joint venture partnership with a group of investors led by Bert Mucci, one of Canada's most sophisticated greenhouse operators and builders. This partnership will function through a newly formed entity, Cronos Growing Company Inc., which will develop, construct and operate a state-of-the-art purpose-built greenhouse for cannabis production in Kingsville, Ontario.

Cronos GrowCo is a 50/50 partnership between the Company and the Greenhouse Partners. It will leverage over three decades of Bert Mucci's experience in designing, building and operating sophisticated large-scale greenhouses. Bert Mucci, has a long history of greenhouse growing experience and will bring a wealth of knowledge and expertise to this collaboration. He has made significant contributions to the horticultural industry in Canada, including investments in innovative technologies and environmental stewardship. With a proven track record of growth and expansions in vertically integrated operations - from seed to package. Bert Mucci has overseen thousands of employees and over 200 acres of fruit and vegetable greenhouses in southwestern Ontario. 

Emblem Corp. announced today that it is making a strategic equity investment into Natura Naturals Inc., a 662,000 square foot licensed greenhouse cultivator of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR"). The companies have also signed a three-year cannabis supply agreement to provide Emblem up to 3,000kg of high-quality cannabis flower per year from Natura’s Phase 1 cultivation facility.

Based in Leamington, Ontario, Natura employs proprietary processes to produce high-quality cannabis in its state-of-the-art greenhouse facility. The first 155,000 square feet of the facility is currently being converted as part of its Phase 1 retrofit and is expected to be complete in August 2018 and capable of producing 15,000kg of cannabis per year. The Phase 2 conversion will retrofit the remaining 507,000 square feet for cannabis cultivation and is expected to bring total production capacity to approximately 70,000kg per year by mid-2019. Natura holds a genetic library of 32 cannabis strains, which will be made available to Emblem.

Post-closing, Emblem will own approximately 5% of Natura’s outstanding shares on a non-diluted basis, and 7% on a fully diluted basis.  Closing of the Equity Investment is subject to customary conditions and is expected to close later this week.

INVICTUS MD STRATEGIES CORP. announced that further to its news release dated May 16, 2018, it has successfully entered into a definitive option agreement with a Late-Stage Applicant under the Access to Cannabis for Medical Purposes Regulations ("ACMPR") to acquire 100% of the outstanding shares of OptionCo from its current shareholders.

OptionCo has a cannabis production and research facility located in Delta, British Columbia, and an additional property located in Mission, British Columbia that is currently awaiting construction of a 350,000 square foot purpose-built indoor facility, which will be built in multiple phases with completion set for the fourth quarter of 2019. The Mission Location is located on 32-acres of buildable land. The property is eligible for wholesale energy costs with 38 MG Watt service at the property line, and access to an ample water supply from underground aquifers.

The Delta Facility has completed its pre-license inspection from Health Canada and expects to receive its license to cultivate medical cannabis under the ACMPR in short order.

Namaste Technologies Inc. announced that the Company has signed an e-commerce and technology services agreement with BlissCo Cannabis Corp Inc. (CNSX: BLIS), whereby Namaste will provide services including access to Namaste's technology platforms, software integrations and e-commerce services including those powered by Namaste's e-commerce artificial intelligence (AI) platform, Findify.io.

Under the terms of this Agreement, Namaste will leverage its proprietary technology platforms to develop an innovative online marketplace in partnership with BlissCo to enhance BlissCo's patient experience. BlissCo is a Canadian licensed producer and distributor of high-quality medical cannabis that operates an Access to Cannabis for Medical Purposes Regulations ("ACMPR") cultivation facility based in Langley, BC.

True Leaf Medicine International Ltd., a plant-forward wellness brand for people and their pets, announced today that construction of its cannabis cultivation and production facility, True Leaf Campus, remains on schedule for fall 2018 completion.

The first phase of the project includes a two-storey 9,000 square foot central hub for the initial grow area, laboratory services, whole-plant extraction, and the production of therapeutic cannabis products, followed by a 16,000 square foot wing for cannabis cultivation. The facilities, being built in Lumby, British Columbia, will be a hub for the development of the company’s medicinal cannabis products.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


This podcast is sponsored by Lexaria Bioscience Corp. ( CSE: LXX) (OTC: LXRP)

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECHTM delivery technology. Lexaria's technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.  
Investorideas.com cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site  Global Cannabis Investing at www.Globalcannabisinvesting.com

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp


Follow us on Social Media




Contact Investorideas.com
800-665-0411




Do you trade or invest in Marijuana / Hemp Stocks?  Check out our stock directory of publicly traded  CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
Join our Group on Linkedin  and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing